Source: MarketScreener

Quantum Genomics: Quantum Genomics : Quantum Genomics gives an update

(marketscreener.com) Quantum Genomics gives an update Quantum Genomics , a biopharmaceutical company specialising in the development of a new class of medications that directly target the brain gives an update following the negative FRESH study results' announcement of last October 28, 2022. Cash position Cash position of the Company was M€ 10.6 as...https://www.marketscreener.com/quote/stock/QUANTUM-GENOMICS-16253203/news/Quantum-Genomics-Quantum-Genomics-gives-an-update-42507694/?utm_medium=RSS&utm_content=20221208

Read full article »
Annual Revenue
$100K-5.0M
Employees
1-25
Jean-Philippe Milon's photo - CEO of Quantum Genomics

CEO

Jean-Philippe Milon

CEO Approval Rating

90/100

Read more